News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Jessica Leech, BS

Articles by Jessica Leech, BS

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

ByWilliam C. Stewart, MD,Jessica Leech, BS,Elizabeth D. Sharpe, MD,John Kulze, MD,John Ellyn, MD,Douglas G. Day, MD

August 1st 2002

Latest Updated Articles

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension
Published: August 1st 2002 | Updated:

Trending on AJMC

House Republicans Block Vote on ACA Subsidy Extension

ICYMI: Highlights From the 2025 ASPC Congress on CVD Prevention

Higher BMI, IBD Linked to Hidradenitis Suppurativa Risk via Mendelian Randomization

Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis

FDA Approves Rucaparib in BRCA-Mutated mCRPC

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.